Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | NPC1 | O15118 | 4/20 | 0.58 |
| ▸ | RAB9A | P51151 | 4/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23421104 | 0.91 | ALDH1A1 (0.56) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL22461353 | 0.88 | MAPT (0.48) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL22461354 | 0.85 | TSHR (0.46) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL26479390 | 0.83 | ALDH1A1 (0.46) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL22461350 | 0.83 | MAPT (0.46) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL22461351 | 0.83 | MAPT (0.43) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL23420688 | 0.83 | MAPT (0.43) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL3497274 | 0.82 | MAPT (0.64) | MAPTALDH1A1NPC1GAACYP3A4 | |
| SCHEMBL6816673 | 0.82 | ALDH1A1 (0.63) | MAPTALDH1A1SMN1; SMN2GAAKDM4E | |
| SCHEMBL6983298 | 0.81 | MAPT (0.68) | MAPTALDH1A1NPC1GAACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112469306-B | Composition, artificial nail composition, nail decorating material, artificial nail, storage container, image forming apparatus, and image forming method | 株式会社理光 | 2024-07-05 | — | — | CN | disclosed |
| US-12023398-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | RICOH COMPANY, LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-12023398-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | RICOH COMPANY, LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-12023398-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | RICOH COMPANY, LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-20230135413-A1 | CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230135413-A1 | CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230135413-A1 | CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| EP-3431557-B1 | COMPOSITION, CURED PRODUCT, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH CO LTD (JP) | 2022-01-12 | — | — | EP | disclosed |
| US-11208516-B2 | Composition, cured product, storage container, image forming apparatus, and image forming method | RICOH COMPANY, LTD. (JP) | 2021-12-28 | — | — | US | disclosed |
| US-11208516-B2 | Composition, cured product, storage container, image forming apparatus, and image forming method | RICOH COMPANY, LTD. (JP) | 2021-12-28 | — | — | US | disclosed |
| US-9593248-B2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | RICOH COMPANY, LTD. (JP) | 2017-03-14 | — | — | US | disclosed |
| US-9593248-B2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | RICOH COMPANY, LTD. (JP) | 2017-03-14 | — | — | US | disclosed |
| EP-3129371-A1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | Syros Pharmaceuticals, Inc. (US) | 2017-02-15 | — | — | EP | disclosed |
| WO-2015154022-A1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | SYROS PHARMACEUTICALS, INC. (US) | 2015-10-08 | — | — | WO | disclosed |
| WO-2015154022-A1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | SYROS PHARMACEUTICALS, INC. (US) | 2015-10-08 | — | — | WO | disclosed |
| US-20140363634-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | RICOH COMPANY, LTD. (JP) | 2014-12-11 | — | — | US | disclosed |
| US-20140363634-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | RICOH COMPANY, LTD. (JP) | 2014-12-11 | — | — | US | disclosed |
| EP-2810996-A2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | Ricoh Company, Ltd. (JP) | 2014-12-10 | — | — | EP | disclosed |
| WO-2005016883-A2 | ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF | ICOS CORPORATION (US) | 2005-02-24 | — | — | WO | disclosed |
| WO-2005016883-A2 | ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF | ICOS CORPORATION (US) | 2005-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140363634-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | CDKN1A, MAPK9, SFRP1 | MAPT 243/4885ALDH1A1 883/4885SMN1; SMN2 2258/4885 |
| US-12023398-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | NACA, PIK3C3, POLR1C | MAPT 221/4885ALDH1A1 1104/4885SMN1; SMN2 3333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.